BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11240033)

  • 1. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling.
    Misu T; Onodera H; Fujihara K; Matsushima K; Yoshie O; Okita N; Takase S; Itoyama Y
    J Neuroimmunol; 2001 Mar; 114(1-2):207-12. PubMed ID: 11240033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
    Høglund RA; Hestvik AL; Holmøy T; Maghazachi AA
    Hum Immunol; 2011 Feb; 72(2):124-34. PubMed ID: 20977917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
    Nakajima H; Fukuda K; Doi Y; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
    Eur Neurol; 2004; 52(3):162-8. PubMed ID: 15528917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Kubo S; Kabasawa C; Kobayashi M; Ohashi T; Uchiyama S
    Eur Neurol; 2011; 66(2):91-7. PubMed ID: 21846991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Balashov KE; Rottman JB; Weiner HL; Hancock WW
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
    Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
    J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.
    Mahad DJ; Lawry J; Howell SJ; Woodroofe MN
    Mult Scler; 2003 Mar; 9(2):189-98. PubMed ID: 12708814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
    Sebastiani S; Allavena P; Albanesi C; Nasorri F; Bianchi G; Traidl C; Sozzani S; Girolomoni G; Cavani A
    J Immunol; 2001 Jan; 166(2):996-1002. PubMed ID: 11145678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
    Teleshova N; Pashenkov M; Huang YM; Söderström M; Kivisäkk P; Kostulas V; Haglund M; Link H
    J Neurol; 2002 Jun; 249(6):723-9. PubMed ID: 12111306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Th1- and Th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia.
    Zhou SF; Ma J; Qu HT; Liu ZT; He WD; Wang JD; Dou AX; Zhang N; Liu JL; Guo CS; Shi Y; Hou M; Peng J
    J Clin Immunol; 2013 Jul; 33(5):938-46. PubMed ID: 23494742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.
    Norii M; Yamamura M; Iwahashi M; Ueno A; Yamana J; Makino H
    Acta Med Okayama; 2006 Jun; 60(3):149-57. PubMed ID: 16838043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemokines and chemokine receptors in multiple sclerosis].
    Misu T; Fujihara K; Itoyama Y
    Nihon Rinsho; 2003 Aug; 61(8):1422-7. PubMed ID: 12962033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective lymphocyte chemokine receptor expression in the rheumatoid joint.
    Ruth JH; Rottman JB; Katschke KJ; Qin S; Wu L; LaRosa G; Ponath P; Pope RM; Koch AE
    Arthritis Rheum; 2001 Dec; 44(12):2750-60. PubMed ID: 11762935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis.
    Katchar K; Eklund A; Grunewald J
    J Intern Med; 2003 Dec; 254(6):564-71. PubMed ID: 14641797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of chemokine receptors on Th1/Th2 CD4+ lymphocytes in patients with multiple sclerosis.
    Andalib A; Doulabi H; Najafi M; Tazhibi M; Rezaie A
    Iran J Immunol; 2011 Mar; 8(1):1-10. PubMed ID: 21427490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased CD14+CCR2+ monocytes in active multiple sclerosis.
    Nakajima H; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
    Neurosci Lett; 2004 Jun; 363(2):187-9. PubMed ID: 15172112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.
    Sørensen TL; Sellebjerg F
    Neurology; 2001 Oct; 57(8):1371-6. PubMed ID: 11673573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.
    Kivisäkk P; Trebst C; Liu Z; Tucky BH; Sørensen TL; Rudick RA; Mack M; Ransohoff RM
    Clin Exp Immunol; 2002 Sep; 129(3):510-8. PubMed ID: 12197893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.